Short-course whole-brain radiotherapy (WBRT) for brain metastases due to small-cell lung cancer (SCLC)

Clinical Neurology and Neurosurgery

Volumn 112, Issue 3, 2010, Pages 183-187

  Bohlen, Guenther ^a   Meyners, Thekla ^a   Kieckebusch, Susanne ^b   Lohynska, Radka ^c   Veninga, Theo ^d   Stalpers, Lukas J A ^e   Schild, Steven E ^f   Rades, Dirk ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c CHARLES UNIVERSITY   (Czech Republic)

^d DR BERNARD VERBEETEN INSTITUTE   (Netherlands)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

^f MAYO CLINIC   (United States)

Author keywords

Brain metastases; Local control; Overall survival; Palliative treatment; Small cell lung cancer; Whole brain radiotherapy

Indexed keywords

DEXAMETHASONE;

ACUTE TOXICITY; ADULT; AGED; ARTICLE; BRAIN METASTASIS; BRAIN RADIATION; CANCER CONTROL; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; GENDER; GROUPS BY AGE; HEADACHE; HUMAN; KARNOFSKY PERFORMANCE STATUS; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NAUSEA; OVERALL SURVIVAL; PROGNOSIS; RADIATION DOSE; RETROSPECTIVE STUDY; SHORT COURSE THERAPY; VOMITING; WHOLE BRAIN RADIOTHERAPY;

AGE FACTORS; AGED; BRAIN NEOPLASMS; CRANIAL IRRADIATION; FEMALE; HUMANS; KARNOFSKY PERFORMANCE STATUS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SMALL CELL LUNG CARCINOMA; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77249119642     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clineuro.2009.11.004     Document Type: Article

References (34)

1. Samson D.J., Seidenfeld J., Simon G.R., Turrisi III A.T., Bonnell C., Ziegler K.M., et al. Evidence for management of small cell lung cancer. ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132 (2007) 314S-323S
2. Arnold S.M., and Patchell R.A. Diagnosis and management of brain metastases. Hematol Oncol Clin North Am 15 (2001) 1085-1107
3. Wen P.Y., Black P.M., and Loeffler J.S. Metastatic brain cancer. In: deVita V., Hellman S., and Rosenberg S.A. (Eds). Cancer: principles and practice of oncology. 6th edition (2001), Lippincott, Williams & Wilkins, Philadelphia 2655-2670
4. Zimm S., Wampler G.L., Stablein D., Hazra T., and Young H.F. Intracerebral metastases in solid tumor patients: natural history and results of treatment. Cancer 48 (1981) 384-394
5. Sundstrom J.T., Minn H., Lertola K.K., and Nordman E. Prognosis of patients treated for intracranial metastases with whole-brain irradiation. Ann Med 30 (1998) 296-299
6. Harwood A.R., and Simson W.J. Radiation therapy of cerebral metastases: a randomized prospective clinical trial. Int J Radiat Oncol Biol Phys 2 (1977) 1091-1094
7. Priestman T.J., Dunn J., Brada M., Rampling R., and Baker P.G. Final results of the Royal College of Radiologists trial comparing two different radiotherapy schedules in the treatment of cerebral metastases. Clin Oncol 8 (1996) 308-315
8. Borgelt B., Gelber R., Kramer S., Brady L.W., Chang C.H., Davis L.W., et al. The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 6 (1980) 1-9
9. Borgelt B., Gelber R., Larson M., Hendrickson F., Griffin T., and Roth R. Ultra-rapid high dose irradiation schedules for the palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 7 (1981) 1633-1638
10. Chatani M., Matayoshi Y., Masaki N., and Inoue T. Radiation therapy for brain metastases from lung carcinoma. Prospective randomized trial according to the level of lactate dehydrogenase. Strahlenther Onkol 170 (1994) 155-161
11. Rades D., Bohlen G., Dunst J., Lohynska R., Veninga T., Stalpers L., et al. Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases. Strahlenther Onkol 184 (2008) 30-35
12. Rades D., Kieckebusch S., Lohynska R., Lohynska R., Veninga T., Stalpers L.J., et al. Reduction of overall treatment time in patients irradiated for more than three brain metastases. Int J Radiat Oncol Biol Phys 69 (2007) 1509-1513
13. Lagerwaard F.J., Levendag P.C., Nowak P.J.C.M., Eijkenboom W.M.H., Hanssens P.E.J., and Schmitz P.I.M. Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Biol Phys 43 (1999) 795-803
14. Gaspar L., Scott C., Rotman M., Asbell S., Phillips T., Wasserman T., et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37 (1997) 745-751
15. Kaplan E.L., and Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
16. Trotti A., Byhardt R., Stetz J., Gwede C., Corn B., Fu K., et al. Common toxicity criteria: version 2.0. An improved reference for grading the acute effects of cancer treatment: impact on radiotherapy. Int J Radiat Oncol Biol Phys 47 (2000) 13-47
17. Bruner D.W., and Wasserman T. The impact on quality of life by radiation late effects. Int J Radiat Oncol Biol Phys 31 (1995) 1353-1355
18. DeAngelis L.M., Delattre J.Y., and Posner J.B. Radiation-induced dementia in patients cured of brain metastases. Neurology 39 (1989) 789-796
19. Joiner M.C., and Van der Kogel A.J. The linear-quadratic approach to fractionation and calculation of isoeffect relationships. In: Steel G.G. (Ed). Basic clinical radiobiology (1997), Oxford University Press, New York 106-112
20. Glatstein E. Hypofractionation, long-term effects, and the alpha/beta ratio. Int J Radiat Oncol Biol Phys 72 (2008) 11-18
21. Mehta M., and Fowler J. Accelerated hypofractionation. Int J Radiat Oncol Biol Phys 61 (2005) 299-313
22. Rades D., Lohynska R., Veninga T., Stalpers L.J., and Schild S.E. Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients. Cancer 110 (2007) 2587-2592
23. Rades D., Schild S.E., Lohynska R., Veninga T., Stalpers L.J., and Dunst J. Two radiation regimens and prognostic factors for brain metastases in nonsmall cell lung cancer patients. Cancer 110 (2007) 1077-1082
24. Rades D., Bohlen G., Lohynska R., Veninga T., Stalpers L.J., Schild S.E., et al. Whole-brain radiotherapy with 20 Gy in 5 fractions for brain metastases in patients with cancer of unknown primary (CUP). Strahlenther Onkol 183 (2007) 631-636
25. Videtic G.M., Adelstein D.J., Mekhail T.M., Rice T.W., Stevens G.H., Lee S.Y., et al. Validation of the RTOG recursive partitioning analysis (RPA) classification for small-cell lung cancer-only brain metastases. Int J Radiat Oncol Biol Phys 67 (2007) 240-243
26. Andrews D.W., Scott C.B., Sperduto P.W., Flanders A.E., Gaspar L.E., Schell M.C., et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363 (2004) 1665-1672
27. Parikh S., and Heron D.E. Fractionated radiosurgical management of intramedullary spinal cord metastasis: a case report and review of the literature. Clin Neurol Neurosurg 111 (2009) 858-861
28. Kondziolka D., Patel A., Lunsford L.D., Kassam A., and Flickinger J.C. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys 45 (1999) 427-434
29. Pirzkall A., Debus J., Lohr F., Fuss M., Rhein B., Engenhart-Cabillic R., et al. Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases. J Clin Oncol 16 (1998) 3563-3569
30. Sneed P.K., Lamborn K.R., Forstner J.M., McDermott M.W., Chang S., Park E., et al. Radiosurgery for brain metastases: is whole brain radiotherapy necessary?. Int J Radiat Oncol Biol Phys 43 (1999) 549-558
31. Aoyama H., Shirato H., Tago M., Nakagawa K., Toyoda T., Hatano K., et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases. A randomized controlled trial. JAMA 295 (2006) 2483-2491
32. Aoyama H., Tago M., Kato N., Toyoda T., Kenjyo M., Hirota S., et al. Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. Int J Radiat Oncol Biol Phys 68 (2007) 1388-1395
33. Meyers C.A., Smith J.A., Bezjak A., Mehta M.P., Liebmann J., Illidge T., et al. Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial. J Clin Oncol 22 (2004) 157-165
34. Rades D., Kueter J.D., Hornung D., Veninga T., Hanssens P., Schild S.E., et al. Comparison of stereotactic radiosurgery (SRS) alone and whole brain radiotherapy (WBRT) plus a stereotactic boost (WBRT + SRS) for one to three brain metastases. Strahlenther Onkol 184 (2008) 655-662